About this trial
The aim of the study is to evaluate whether walking capacity in patients with intermittent claudication is improved more by home-based 5+ exercise training than by current recommendations of daily walking.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Pain in the calves after 300 m, or less measured on a treadmill
Stable symptoms last 6 months or more
The pain must be gone within 5 minutes after the patients stop walking
Ankle-Brachial index at 0.7 or lower at rest
Disqualifiers
pain in the hips or elsewhere outside the calves while walking
Remaining pain more than 5 minutes after stopped walking.
Impossible to compress the arteries while measruing ABI or ABI lower than 0.4
Use of statins and antiplatelet drugs less than 3 months
Trial design
Single group
Treatments tested in this trial
Physical training
BehavioralThe patients are randomized to either walking 30 minutes 3 times a week or lifting the body to a tip toe position three times a day until pain in the claves and then add another five liftings before ending the session
Treatment groups
Trial outcomes
Primary outcomes
walking distance
Measured on a tread mill before and after the training period
Quality of life
Measured with a questionnaire (VASCUQOL-6) before and after the training period
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Norwegian University of Science and Technology
Lead sponsor
Sykehuset i Vestfold HF
Collaborator
Oslo University Hospital
Collaborator
Haukeland University Hospital
Collaborator
Sorlandet Hospital HF
Collaborator
St. Olavs Hospital
Collaborator
Sykehuset Ostfold
Collaborator
Helse Stavanger HF
Collaborator
Sykehuset Innlandet HF
Collaborator
Drammen sykehus
Collaborator
Alesund Hospital
Collaborator
Sahlgrenska University Hospital
Collaborator
Karolinska Institutet
Collaborator
University Hospital, Linkoeping
Collaborator